I have respiratory failure with anxiety and am taking Cymbalta (duloxetine) 30 mg twice daily; should I increase the dose?

Do Not Increase Cymbalta Dose - Address Respiratory Failure First

You should NOT increase your Cymbalta dose at this time. Your anxiety is likely secondary to your respiratory failure, and increasing duloxetine will not address the underlying life-threatening respiratory problem and may worsen respiratory depression.

Critical Safety Concerns

Respiratory failure is a medical emergency that requires immediate evaluation and treatment of the underlying cause. Anxiety in the setting of respiratory failure is typically a symptom of hypoxia, hypercapnia, or the distress of dyspnea itself—not a primary psychiatric condition requiring dose escalation of an antidepressant 1.

Why Not to Increase Duloxetine

• Your current dose (30 mg BID = 60 mg total daily) is already at the FDA-approved target dose for generalized anxiety disorder 2
• The FDA label clearly states: "there is no evidence that doses greater than 60 mg/day confer additional benefit" for anxiety 2
• Higher doses (up to 120 mg/day) are associated with higher rates of adverse reactions without additional efficacy 2
• Benzodiazepines and sedating medications can worsen respiratory depression in patients with respiratory failure 1

What You Should Do Instead

Immediate Actions

1. Seek urgent medical evaluation for your respiratory failure

   • Assess oxygen saturation, arterial blood gases
   • Identify and treat the underlying cause (COPD exacerbation, pneumonia, pulmonary embolism, etc.)
   • Optimize respiratory support (oxygen, non-invasive ventilation, bronchodilators)

2. Treat the respiratory failure first - anxiety will likely improve once breathing improves and oxygenation is restored 1

3. Consider non-pharmacologic anxiety management:

   • Breathing retraining techniques
   • Positioning for optimal breathing
   • Reassurance and supportive communication
   • Treatment of underlying dyspnea

If Anxiety Persists After Respiratory Stabilization

Only after your respiratory status is stabilized, if anxiety remains problematic:

• Continue current Cymbalta dose (60 mg total daily) - this is the evidence-based target dose 2
• Consider adding cognitive-behavioral therapy, which has strong evidence for anxiety disorders 3
• If medication adjustment is needed, discuss with your physician whether a different class might be appropriate (though SNRIs like duloxetine are first-line for generalized anxiety) 3

Common Pitfalls to Avoid

• Do not treat anxiety symptoms in isolation when they are secondary to a life-threatening medical condition 1
• Avoid benzodiazepines (like lorazepam, midazolam) in respiratory failure as they can cause respiratory depression 4, 1
• Do not assume more medication equals better control - duloxetine shows no additional benefit above 60 mg/day for anxiety 2

Duloxetine Dosing Facts for Anxiety

According to FDA labeling 2:

• Starting dose: 30 mg once daily for 1 week, then increase to 60 mg once daily
• Target dose: 60 mg once daily
• Maximum studied dose: 120 mg once daily
• Key finding: "there is no evidence that doses greater than 60 mg/day confer additional benefit"

Your current regimen of 30 mg BID (60 mg total daily) is already at the recommended therapeutic dose. Research confirms that doses above 60 mg/day provide no additional anxiety reduction but do increase side effects 5, 6, 7, 8.

Bottom line: Your respiratory failure needs urgent medical attention. The anxiety is likely a symptom of inadequate oxygenation or breathing distress, not inadequate duloxetine dosing.